With profitability forecast in 2025 and bullish guidance to boot, IMO would be absolutely mad to be selling this stock before profitability. Looking back at medical devices that have simplicity and applicability at their core, that change the standard of care and sweep the globe, they have made an absolute fortune commercially. Laryngeal Mask Airway (LMA) and penthrane whistle (the green whistle for pain relief) are two examples that have changed medical care and been huge commercial success stories. Everything points towards ReCell doing the same by vastly reducing the need for skin grafting pain and disfigurement the world over. IMO you'd be nuts to see until at least profitability, when the big fish will start to bite.
-
- There are more pages in this discussion • 347 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
0.040(2.26%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| $1.79 | $1.83 | $1.77 | $166.2K | 92.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17378 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 254 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| AVH (ASX) Chart |